Equities
Health CarePharmaceuticals & Biotechnology
  • Price (DKK)358.60
  • Today's Change-4.20 / -1.16%
  • Shares traded397.52k
  • 1 Year change17.54%
  • Beta1.0369
Data delayed at least 15 minutes, as of Feb 25 2020 15:59 GMT.
More ▼

Key statistics

On Tuesday, Novozymes A/S (NZYM B:CPH) closed at 358.60, -6.91% below its 52-week high of 385.20, set on Feb 19, 2020.
52-week range
Today
267.50Aug 28 2019385.20Feb 19 2020
Markit short selling activity
Low
Med
High
Open362.20
High366.20
Low353.70
Bid358.60
Offer--
Previous close362.80
Average volume312.12k
Shares outstanding237.26m
Free float159.48m
P/E (TTM)32.94
Market cap86.08bn DKK
EPS (TTM)11.01
DKK
Annual div (ADY)5.25
DKK
Annual div yield (ADY)1.45%
Div ex-dateFeb 28 2019
Div pay-dateMar 04 2019
Next div ex-dateFeb 27 2020
Next div pay-dateMar 02 2020
Data delayed at least 15 minutes, as of Feb 25 2020 15:59 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.